Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 1 (2004), Issue 2 (December)

1. Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes.
   Nat Rev Immunol, 4(12): 989-97. [Abstract] [Full-text]
2. Fetal hyperinsulinism and maternal one-hour postload plasma glucose level.
   Obstet Gynecol, 104(6): 1301-6. [Abstract] [Full-text]
3. IA-2 antibody epitopes and isotypes during the prediabetic process in siblings of children with type 1 diabetes.
   J Autoimmun, 23(4): 361-70. [Abstract] [Full-text]
4. Gene expression profiling in type 1 diabetes prone NOD mice immunized with a disease protective autoantigenic peptide.
   J Autoimmun, 23(4): 311-21. [Abstract] [Full-text]
5. Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas.
   J Autoimmun, 23(4): 301-9. [Abstract] [Full-text]
6. Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice.
   J Autoimmun, 23(4): 293-300. [Abstract] [Full-text]
7. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range.
   Eur Heart J, 25(23): 2120-4. [Abstract] [Full-text]
8. Evaluating mechanisms of post-transplant diabetes mellitus.
   Nephrol Dial Transplant, 19: vi8-vi12. [Abstract] [Full-text]
9. Improving long-term renal transplant outcomes with tacrolimus: speculation vs evidence.
   Nephrol Dial Transplant, 19: vi17-vi22. [Abstract] [Full-text]
10. Post-transplant diabetes mellitus: the last 10 years with tacrolimus.
    Nephrol Dial Transplant, 19: vi13-vi16. [Abstract] [Full-text]
11. Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.
    Nephrol Dial Transplant, 19(12): 3012-20. [Abstract] [Full-text]
12. Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis.
    Nephrol Dial Transplant, 19(12): 2987-96. [Abstract] [Full-text]
13. Gestational diabetes: the meaning of an at-risk pregnancy.
    Qual Health Res, 15(1): 66-81. [Abstract] [Full-text]
14. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report.
    Pediatrics, 114(6): 1601-5. [Abstract] [Full-text]
15. Unpacking the black box: a deconstruction of the programming approach and physical activity interventions implemented in the Kahnawake Schools Diabetes Prevention Project.
    Health Promot Pract, 6(1): 64-71. [Abstract] [Full-text]
16. Diabetes-induced expression of activating transcription factor 3 in mouse primary sensory neurons.
    J Peripher Nerv Syst, 9(4): 242-54. [Abstract] [Full-text]
17. Plasticity of the different neuropeptide-containing nerve fibres in the tongue of the diabetic rat.
    J Peripher Nerv Syst, 9(4): 215-23. [Abstract] [Full-text]
18. Influence of hepatocyte-rich liver cell mixture and liver fibroblasts on prolonging graft islet survival in rats without immunosuppressive drugs.
    Exp Clin Endocrinol Diabetes, 112(10): 580-6. [Abstract] [Full-text]
19. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes.
    Exp Clin Endocrinol Diabetes, 112(10): 566-73. [Abstract] [Full-text]
20. Coronary calcification in long-term type 1 diabetic patients -- a study with multi slice spiral computed tomography.
    Exp Clin Endocrinol Diabetes, 112(10): 561-5. [Abstract] [Full-text]
21. Introductory experience with the continuous glucose monitoring system (CGMS; Medtronic Minimed) in detecting hyperglycemia by comparing the self-monitoring of blood glucose (SMBG) in non-pregnant women and in pregnant women with impaired glucose tolerance and gestational diabetes.
    Exp Clin Endocrinol Diabetes, 112(10): 556-60. [Abstract] [Full-text]
22. Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study.
    Cancer Causes Control, 15(9): 873-81. [Abstract] [Full-text]
23. Race, rural residence, and control of diabetes and hypertension.
    Ann Fam Med, 2(6): 563-8. [Abstract] [Full-text]
24. Pioglitazone in the management of diabetes mellitus after transplantation.
    Am J Transplant, 4(12): 2135-8. [Abstract] [Full-text]
25. Intravitreal triamcinolone for diabetic macular oedema in Chinese patients: six-month prospective longitudinal pilot study.
    Clin Experiment Ophthalmol, 32(6): 569-72. [Abstract] [Full-text]
26. Anthropometry, metabolic control, and thyroid autoimmunity in type 1 diabetes with celiac disease: A multicenter survey.
    J Pediatr, 145(6): 790-5. [Abstract] [Full-text]
27. Residual beta-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes.
    J Clin Endocrinol Metab, 89(12): 6305-9. [Abstract] [Full-text]
28. Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study.
    J Clin Endocrinol Metab, 89(12): 6286-90. [Abstract] [Full-text]
29. Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: evidence for independent effects of two polymorphisms on the same haplotype block.
    J Clin Endocrinol Metab, 89(12): 6257-65. [Abstract] [Full-text]
30. A low-carbohydrate/high-fat diet improves glucoregulation in type 2 diabetes mellitus by reducing postabsorptive glycogenolysis.
    J Clin Endocrinol Metab, 89(12): 6193-7. [Abstract] [Full-text]
31. Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial.
    J Clin Endocrinol Metab, 89(12): 6068-76. [Abstract] [Full-text]
32. Rosiglitazone, but not glyburide, reduces circulating proinsulin and the proinsulin:insulin ratio in type 2 diabetes.
    J Clin Endocrinol Metab, 89(12): 6048-53. [Abstract] [Full-text]
33. Posterior pituitary dysfunction after traumatic brain injury.
    J Clin Endocrinol Metab, 89(12): 5987-92. [Abstract] [Full-text]
34. Nodules of fibrocollagenous scar tissue induced by subcutaneous insulin injections: a cause of poor diabetic control.
    Postgrad Med J, 80(950): 732-3. [Abstract] [Full-text]
35. Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal.
    J Am Soc Nephrol, 15(12): 3233-9. [Abstract] [Full-text]
36. Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus.
    J Am Soc Nephrol, 15(12): 3166-74. [Abstract] [Full-text]
37. Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results.
    J Am Soc Nephrol, 15(12): 3117-25. [Abstract] [Full-text]
38. Glucose tolerance and risk of gestational diabetes mellitus in nulliparous women who smoke during pregnancy.
    Am J Epidemiol, 160(12): 1205-13. [Abstract] [Full-text]
39. Promoting health in type 2 diabetes: nurse-physician collaboration in primary care.
    Biol Res Nurs, 6(3): 207-15. [Abstract] [Full-text]
40. Relationships between maternal and child cardiovascular risk factors: ethnic differences and lack of influence of physical activity.
    Arch Pediatr Adolesc Med, 158(12): 1125-31. [Abstract] [Full-text]
41. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines.
    Endocr Rev, 25(6): 971-1010. [Abstract] [Full-text]
42. 2-Alkoxydihydrocinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituents.
    Bioorg Med Chem Lett, 15(1): 51-5. [Abstract] [Full-text]
43. The participation roles of children and adolescents in the dietary counseling of diabetics.
    Patient Educ Couns, 55(3): 385-95. [Abstract] [Full-text]
44. Reduced glomerular filtration rate in asymptomatic diabetic patients: predictor of increased risk for cardiac events independent of albuminuria.
    J Am Coll Cardiol, 44(11): 2142-8. [Abstract] [Full-text]
45. Biochemical study on the hypoglycemic effects of onion and garlic in alloxan-induced diabetic rats.
    Food Chem Toxicol, 43(1): 57-63. [Abstract] [Full-text]
46. Expression of axotomy-inducible and apoptosis-related genes in sensory nerves of rats with experimental diabetes.
    Brain Res Mol Brain Res, 132(2): 235-40. [Abstract] [Full-text]
47. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes.
    Life Sci, 76(7): 715-30. [Abstract] [Full-text]
48. Preserved LTP and water maze learning in hyperglycaemic-hyperinsulinemic ZDF rats.
    Physiol Behav, 83(3): 483-94. [Abstract] [Full-text]
49. MRI of transplanted pancreatic islets.
    Magn Reson Med, 52(6): 1228-33. [Abstract] [Full-text]
50. Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats.
    Am J Physiol Endocrinol Metab, 288(1): E29-36. [Abstract] [Full-text]
51. Differing physiological effects of epinephrine in type 1 diabetes and nondiabetic humans.
    Am J Physiol Endocrinol Metab, 288(1): E178-86. [Abstract] [Full-text]
52. Beta-cell CaV channel regulation in physiology and pathophysiology.
    Am J Physiol Endocrinol Metab, 288(1): E16-28. [Abstract] [Full-text]
53. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Pharmacotherapy, 24(12): 1692-713. [Abstract] [Full-text]
54. Interleukin IL-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults.
    Immunol Lett, 96(2): 247-51. [Abstract] [Full-text]
55. Relationship between gene polymorphisms and prevalence of myocardial infarction among diabetic and non-diabetic subjects.
    Atherosclerosis, 178(1): 101-5. [Abstract] [Full-text]
56. Poor in vitro maturation and pro-inflammatory cytokine response of dendritic cells in children at genetic risk of type 1 diabetes.
    Scand J Immunol, 60(6): 647-52. [Abstract] [Full-text]
57. Rational pharmacotherapy in the diabetic hypertension: analysis-prescribing patterns in a general hospital in Taiwan.
    J Clin Pharm Ther, 29(6): 547-58. [Abstract] [Full-text]
58. Selection of glycoprotein IIb/IIIa inhibitors for upstream use in patients with diabetes experiencing unstable angina or non-ST segment elevation myocardial infarction. What have we learned in the last 10 years?
    J Clin Pharm Ther, 29(6): 497-510. [Abstract] [Full-text]
59. Optic nerve atrophy after vitrectomy with indocyanine green-assisted internal limiting membrane peeling in diffuse diabetic macular edema. Adverse effect of ICG-assisted ILM peeling.
    Graefes Arch Clin Exp Ophthalmol, 242(12): 995-9. [Abstract] [Full-text]
60. Fat storage in pancreas and in insulin-sensitive tissues in pathogenesis of type 2 diabetes.
    Int J Obes Relat Metab Disord, 28: S53-7. [Abstract] [Full-text]
61. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus.
    Int J Obes Relat Metab Disord, 28: S12-21. [Abstract] [Full-text]
62. Theory-guided intervention for preventing diabetes-related amputations in African Americans.
    J Vasc Nurs, 22(4): 126-33. [Abstract] [Full-text]
63. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus.
    Am J Obstet Gynecol, 191(6): 2120-4. [Abstract] [Full-text]
64. Effects of exercise and diet on chronic disease.
    J Appl Physiol, 98(1): 3-30. [Abstract] [Full-text]
65. Carnitine in type 2 diabetes.
    Ann N Y Acad Sci, 1033: 99-107. [Abstract] [Full-text]
66. Stem cell therapy for diabetes: do we need to make beta cells?
    J Endocrinol, 183(3): 437-43. [Abstract] [Full-text]
67. Cataract in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.
    Ophthalmic Epidemiol, 11(5): 347-58. [Abstract] [Full-text]
68. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function.
    J Clin Exp Neuropsychol, 26(8): 1044-80. [Abstract] [Full-text]
69. Protective effect of Montilla-Moriles appellation red wine on oxidative stress induced by streptozotocin in the rat.
    J Nutr Biochem, 15(11): 688-93. [Abstract] [Full-text]
70. Adjusting insulin doses: from knowledge to decision.
    Patient Educ Couns, 56(1): 98-103. [Abstract] [Full-text]
71. Promoting glycemic control through diabetes self-management: evaluating a patient activation intervention.
    Patient Educ Couns, 56(1): 28-34. [Abstract] [Full-text]
72. Cyclosporine toxicity in immunosuppressed streptozotocin-diabetic nonhuman primates.
    Toxicology, 207(1): 117-27. [Abstract] [Full-text]
73. Optimized parameters for microencapsulation of pancreatic islet cells: an in vitro study clueing on islet graft immunoprotection in type 1 diabetes mellitus.
    Transpl Immunol, 13(4): 289-96. [Abstract] [Full-text]
74. Coping with stress among Aboriginal women and men with diabetes in Winnipeg, Canada.
    Soc Sci Med, 60(5): 977-88. [Abstract] [Full-text]
75. Sex-associated differences in clinical outcomes after coronary stenting in patients with diabetes mellitus.
    Am J Med, 117(11): 830-6. [Abstract] [Full-text]
76. Successful abrogation by thymoquinone against induction of diabetes mellitus with streptozotocin via nitric oxide inhibitory mechanism.
    Int Immunopharmacol, 5(1): 195-207. [Abstract] [Full-text]
77. 12/15-lipoxygenase inhibitors in diabetic nephropathy in the rat.
    Prostaglandins Leukot Essent Fatty Acids, 72(1): 13-20. [Abstract] [Full-text]
78. Association of an insulin gene promoter insertion polymorphism with type 2 diabetes and diabetic nephropathy in African Americans.
    Mol Genet Metab, 83(4): 344-6. [Abstract] [Full-text]
79. Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome.
    Biomed Pharmacother, 58(10): 614-8. [Abstract] [Full-text]
80. Diabetes mellitus: rational basis, clinical approach and future therapy.
    Biomed Pharmacother, 58(10): 605-9. [Abstract] [Full-text]
81. Healing of diabetic foot ulcers in L-arginine-treated patients.
    Biomed Pharmacother, 58(10): 588-97. [Abstract] [Full-text]
82. Future therapy of diabetes mellitus.
    Biomed Pharmacother, 58(10): 578-81. [Abstract] [Full-text]
83. A comparison between Japanese-Americans living in Hawaii and Los Angeles and native Japanese: the impact of lifestyle westernization on diabetes mellitus.
    Biomed Pharmacother, 58(10): 571-7. [Abstract] [Full-text]
84. Psychosocial factors associated with poor diabetes self-care management in a specialized center in Mexico City.
    Biomed Pharmacother, 58(10): 566-70. [Abstract] [Full-text]
85. Skin vasoreactivity to insulin iontophoresis is reduced in elderly subjects and is absent in treated non-insulin-dependent diabetes patients.
    Biomed Pharmacother, 58(10): 560-5. [Abstract] [Full-text]
86. Hypoglycemia in type 2 diabetes: a critical review.
    Biomed Pharmacother, 58(10): 551-9. [Abstract] [Full-text]
87. Ineffectiveness of allopurinol in reduction of oxidative stress in diabetic patients; a randomized, double-blind placebo-controlled clinical trial.
    Biomed Pharmacother, 58(10): 546-50. [Abstract] [Full-text]
88. Aspects of oxidative stress in children with type 1 diabetes mellitus.
    Biomed Pharmacother, 58(10): 539-45. [Abstract] [Full-text]
89. Remodeling of the innervation of pancreatic islets accompanies insulitis preceding onset of diabetes in the NOD mouse.
    J Neuroimmunol, 158(1): 128-37. [Abstract] [Full-text]
90. Lisofylline: a potential lead for the treatment of diabetes.
    Biochem Pharmacol, 69(1): 1-5. [Abstract] [Full-text]
91. Fruit of the jambolan tree (Eugenia jambolana Lam.) and experimental diabetes.
    J Ethnopharmacol, 96(1): 43-8. [Abstract] [Full-text]
92. Haptoglobin phenotype as a predictive factor of mortality in diabetic haemodialysis patients.
    Ann Clin Biochem, 41: 469-73. [Abstract] [Full-text]
93. Adenovirus early region 3 transgenes expressed in beta cells prevent autoimmune diabetes in nonobese diabetic mice: effects of deleting the adenovirus death protein 11.6K.
    J Virol, 79(1): 619-21. [Abstract] [Full-text]
94. The influence of type 2 diabetes mellitus in patients undergoing coronary artery bypass graft surgery: an 8-year prospective cohort study.
    Chest, 126(6): 1789-95. [Abstract] [Full-text]
95. Aspirin use among adults with diabetes: recent trends and emerging sex disparities.
    Arch Intern Med, 164(22): 2492-9. [Abstract] [Full-text]
96. Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy.
    Arch Ophthalmol, 122(12): 1809-15. [Abstract] [Full-text]
97. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.
    Arch Ophthalmol, 122(12): 1801-7. [Abstract] [Full-text]
98. Large babies and unplanned Caesarean delivery.
    Eur J Obstet Gynecol Reprod Biol, 118(1): 36-9. [Abstract] [Full-text]
99. Androgen, estrogen, and progesterone receptor gene regulation during diabetic erectile dysfunction and insulin treatment.
    Urology, 64(6): 1244-9. [Abstract] [Full-text]
100. The associations of anxiety, depression and personal illness representations with glycaemic control and health-related quality of life in patients with type 2 diabetes mellitus.
     J Psychosom Res, 57(6): 557-64. [Abstract] [Full-text]
101. Molecular therapeutic target for type-2 diabetes.
     J Proteome Res, 3(6): 1284-8. [Abstract] [Full-text]
102. The Gly482Ser polymorphism in the peroxisome proliferator-activated receptor-gamma coactivator-1 gene is associated with hypertension in type 2 diabetic men.
     Diabetologia, 47(11): 1980-3. [Abstract] [Full-text]
103. Physical disability among older Italians with diabetes. The ILSA study.
     Diabetologia, 47(11): 1957-62. [Abstract] [Full-text]
104. Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials.
     Diabetologia, 47(11): 1914-23. [Abstract] [Full-text]
105. Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy.
     Diabetologia, 47(11): 1895-905. [Abstract] [Full-text]
106. Diabetes and inflammation.
     Herz, 29(8): 749-59. [Abstract] [Full-text]
107. Blood pressure in 15 inbred mouse strains and its lack of relation with obesity and insulin resistance in the progeny of an NZO/HILtJ x C3H/HeJ intercross.
     Mamm Genome, 15(12): 943-50. [Abstract] [Full-text]
108. Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.
     J Clin Invest, 114(12): 1741-51. [Abstract] [Full-text]
109. Familial aggregation of juvenile idiopathic arthritis.
     Arthritis Rheum, 50(12): 4022-7. [Abstract] [Full-text]
110. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
     Proc Natl Acad Sci U S A, 101(50): 17539-44. [Abstract] [Full-text]
111. Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies in the offspring of diabetic rats.
     Birth Defects Res A Clin Mol Teratol, 70(12): 927-38. [Abstract] [Full-text]
112. Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition.
     Diabetologia, 47(11): 2012-21. [Abstract] [Full-text]
113. High-sensitivity C-reactive protein and impaired coronary vasoreactivity in young men with uncomplicated type 1 diabetes.
     Diabetologia, 47(11): 1888-94. [Abstract] [Full-text]
114. Reduction of beta cell mass: partial insulin secretory compensation from the residual beta cell population in the nicotinamide-streptozotocin Göttingen minipig after oral glucose in vivo and in the perfused pancreas.
     Diabetologia, 47(11): 1873-8. [Abstract] [Full-text]
115. Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes.
     Diabetologia, 47(11): 1906-13. [Abstract] [Full-text]
116. Diffusing capacity for carbon monoxide in children with type 1 diabetes.
     Diabetologia, 47(11): 1931-5. [Abstract] [Full-text]
117. The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with the risk of type 2 diabetes. The Ludwigshafen Risk and Cardiovascular Health study.
     Diabetologia, 47(11): 1969-73. [Abstract] [Full-text]
118. IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes.
     Diabetologia, 47(11): 1984-9. [Abstract] [Full-text]
119. Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance?
     Diabetologia, 47(11): 1963-8. [Abstract] [Full-text]
120. The p75 neurotrophin receptor appears in plasma in diabetic rats-characterisation of a potential early test for neuropathy.
     Diabetologia, 47(11): 1924-30. [Abstract] [Full-text]
121. Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance.
     Diabetologia, 47(11): 1948-52. [Abstract] [Full-text]
122. Smoking is associated with an increased risk of type 2 diabetes but a decreased risk of autoimmune diabetes in adults: an 11-year follow-up of incidence of diabetes in the Nord-Trøndelag study.
     Diabetologia, 47(11): 1953-6. [Abstract] [Full-text]
123. Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes.
     Pediatr Diabetes, 5(4): 219-26. [Abstract] [Full-text]
124. Addison's disease presenting in four adolescents with type 1 diabetes.
     Pediatr Diabetes, 5(4): 207-11. [Abstract] [Full-text]
125. Continuous subcutaneous insulin infusion in neonatal diabetes mellitus.
     Pediatr Diabetes, 5(4): 202-6. [Abstract] [Full-text]
126. Diabetes in an infant with cystic fibrosis.
     Pediatr Diabetes, 5(4): 199-201. [Abstract] [Full-text]
127. Mealtime interactions in families of pre-schoolers with type 1 diabetes.
     Pediatr Diabetes, 5(4): 190-8. [Abstract] [Full-text]
128. Ponderal gain, waist-to-hip ratio, and pubertal development in girls with type-1 diabetes mellitus.
     Pediatr Diabetes, 5(4): 182-9. [Abstract] [Full-text]
129. Parent responses to participation in genetic screening for diabetes risk.
     Pediatr Diabetes, 5(4): 174-81. [Abstract] [Full-text]
130. Over-expression of the gene (bglBC1) from Bacillus circulans encoding an endo-beta-(1-->3),(1-->4)-glucanase useful for the preparation of oligosaccharides from barley beta-glucan.
     Biotechnol Lett, 26(22): 1749-55. [Abstract] [Full-text]
131. QT interval abnormalities are often present at diagnosis in diabetes and are better predictors of cardiac death than ankle brachial pressure index and autonomic function tests.
     Heart, 91(1): 44-50. [Abstract] [Full-text]
132. Type 1 diabetes in Jewish Ethiopian immigrants in Israel: HLA class II immunogenetics and contribution of new environment.
     Hum Immunol, 65(12): 1463-8. [Abstract] [Full-text]
133. Different HLA-DR-DQ and MHC class I chain-related gene A (MICA) genotypes in autoimmune and nonautoimmune gestational diabetes in a Swedish population.
     Hum Immunol, 65(12): 1443-50. [Abstract] [Full-text]
134. Alleles of the IL12B 3'UTR associate with late onset of type 1 diabetes.
     Hum Immunol, 65(12): 1432-6. [Abstract] [Full-text]
135. Klebsiella pneumoniae fascial space infections of the head and neck in Taiwan: emphasis on diabetic patients and repetitive infections.
     J Infect, 50(1): 34-40. [Abstract] [Full-text]
136. Effect of Lap-Band-induced weight loss on type 2 diabetes mellitus and hypertension.
     Obes Surg, 14(10): 1335-42. [Abstract] [Full-text]
137. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
     Med Princ Pract, 14(1): 22-30. [Abstract] [Full-text]
138. T1DBase, a community web-based resource for type 1 diabetes research.
     Nucleic Acids Res, 33: D544-9. [Abstract] [Full-text]
139. Transcription factors, pancreatic development, and beta-cell maintenance.
     Biochem Biophys Res Commun, 326(4): 699-702. [Abstract] [Full-text]
140. Relationship between plasma leptin and zinc levels and the effect of insulin and oxidative stress on leptin levels in obese diabetic patients.
     J Nutr Biochem, 15(12): 757-60. [Abstract] [Full-text]
141. The low-AGE content of low-fat vegan diets could benefit diabetics - though concurrent taurine supplementation may be needed to minimize endogenous AGE production.
     Med Hypotheses, 64(2): 394-8. [Abstract] [Full-text]
142. Methylenetetrahydrofolate reductase polymorphism associated with susceptibility to coronary heart disease in Chinese type 2 diabetic patients.
     Mol Cell Endocrinol, 229(1): 95-101. [Abstract] [Full-text]
143. Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction.
     J Am Coll Cardiol, 44(12): 2368-74. [Abstract] [Full-text]
144. New aspects in the pathogenesis of diabetic atherothrombosis.
     J Am Coll Cardiol, 44(12): 2293-300. [Abstract] [Full-text]
145. Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions.
     Life Sci, 76(9): 1051-60. [Abstract] [Full-text]
146. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology.
     Eur J Clin Invest, 34(12): 785-96. [Abstract] [Full-text]
147. Hospital in-patients with diabetes: increasing prevalence and management problems.
     Diabet Med, 22(1): 107-9. [Abstract] [Full-text]
148. Soluble transferrin receptors and ferritin in Type 2 diabetic patients.
     Diabet Med, 22(1): 97-101. [Abstract] [Full-text]
149. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life.
     Diabet Med, 22(1): 92-6. [Abstract] [Full-text]
150. Prevalence of diabetes and impaired glucose regulation in 45- to 64-year-old individuals in three areas of Finland.
     Diabet Med, 22(1): 88-91. [Abstract] [Full-text]
151. The association of smoking and subclinical atherosclerosis in Type 2 diabetes: modification by duration of diabetes.
     Diabet Med, 22(1): 81-7. [Abstract] [Full-text]
152. Studies of relationships between variation of the human G protein-coupled receptor 40 Gene and Type 2 diabetes and insulin release.
     Diabet Med, 22(1): 74-80. [Abstract] [Full-text]
153. The TGF-beta 1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes.
     Diabet Med, 22(1): 69-73. [Abstract] [Full-text]
154. Increasing prevalence of Type 2 diabetes mellitus in all ethnic groups in Mauritius.
     Diabet Med, 22(1): 61-8. [Abstract] [Full-text]
155. Interstitial glucose in skeletal muscle of diabetic patients during an oral glucose tolerance test.
     Diabet Med, 22(1): 56-60. [Abstract] [Full-text]
156. Factors predicting the blood glucose lowering effect of a 30-day very low calorie diet in obese Type 2 diabetic patients.
     Diabet Med, 22(1): 52-5. [Abstract] [Full-text]
157. Lifetime glycaemic exposure predicts reduced coronary vasoreactivity in Type 1 diabetic subjects.
     Diabet Med, 22(1): 45-51. [Abstract] [Full-text]
158. Measurement of insulin sensitivity in Type 2 diabetes mellitus: comparison between KITT and HOMA-%S indices and evaluation of their relationship with the components of the insulin resistance syndrome.
     Diabet Med, 22(1): 39-44. [Abstract] [Full-text]
159. Barriers to following dietary recommendations in Type 2 diabetes.
     Diabet Med, 22(1): 32-8. [Abstract] [Full-text]
160. Usefulness of total cholesterol/HDL-cholesterol ratio in the management of diabetic dyslipidaemia.
     Diabet Med, 22(1): 26-31. [Abstract] [Full-text]
161. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance.
     Diabet Med, 22(1): 21-5. [Abstract] [Full-text]
162. Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.
     Diabet Med, 22(1): 14-20. [Abstract] [Full-text]
163. Insulino-mimetic and anti-diabetic effects of vanadium compounds.
     Diabet Med, 22(1): 2-13. [Abstract] [Full-text]
164. Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis.
     Clin Exp Immunol, 139(1): 57-64. [Abstract] [Full-text]
165. Quantitative analysis of retinopathy in type 2 diabetes: identification of prognostic parameters for developing visual loss secondary to diabetic maculopathy.
     Acta Ophthalmol Scand, 82(6): 679-85. [Abstract] [Full-text]
166. Screening for diabetic retinopathy in Denmark: the current status.
     Acta Ophthalmol Scand, 82(6): 673-8. [Abstract] [Full-text]
167. Diabetic retinopathy screening using digital non-mydriatic fundus photography and automated image analysis.
     Acta Ophthalmol Scand, 82(6): 666-72. [Abstract] [Full-text]
168. Screening for diabetic retinopathy using a digital non-mydriatic camera compared with standard 35-mm stereo colour transparencies.
     Acta Ophthalmol Scand, 82(6): 656-65. [Abstract] [Full-text]
169. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
     J Intern Med, 257(1): 100-9. [Abstract] [Full-text]
170. Estimating haplotype-disease associations with pooled genotype data.
     Genet Epidemiol, 28(1): 70-82. [Abstract] [Full-text]
171. The role of innate immunity in autoimmunity.
     J Exp Med, 200(12): 1527-31. [Abstract] [Full-text]
172. Accommodating type 2 diabetes in the Chinese American family.
     Qual Health Res, 15(2): 240-55. [Abstract] [Full-text]
173. Using higher-order crossings to distinguish liver regeneration indices in hepatectomized diabetic and non-diabetic rats.
     J Gastroenterol Hepatol, 20(1): 126-34. [Abstract] [Full-text]
174. Weight gain and new onset diabetes associated with olanzapine and risperidone.
     J Gen Intern Med, 19(12): 1200-5. [Abstract] [Full-text]
175. Cardiac risk factors in patients with diabetes mellitus and major depression.
     J Gen Intern Med, 19(12): 1192-9. [Abstract] [Full-text]
176. Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors.
     J Gen Intern Med, 19(12): 1181-91. [Abstract] [Full-text]
177. Utility of hemoglobin A1c in predicting diabetes risk.
     J Gen Intern Med, 19(12): 1175-80. [Abstract] [Full-text]
178. A practical randomized trial to improve diabetes care.
     J Gen Intern Med, 19(12): 1167-74. [Abstract] [Full-text]
179. Association of reduced red blood cell deformability and diabetic nephropathy.
     Kidney Int, 67(1): 295-300. [Abstract] [Full-text]
180. Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy.
     Kidney Int, 67(1): 167-77. [Abstract] [Full-text]
181. The diabetes-linked transcription factor PAX4 promotes {beta}-cell proliferation and survival in rat and human islets.
     J Cell Biol, 167(6): 1123-35. [Abstract] [Full-text]
182. Effect of diabetes and hypertension on obesity-related mortality.
     Surgery, 137(1): 16-25. [Abstract] [Full-text]
183. Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon.
     J Virol, 79(2): 1045-52. [Abstract] [Full-text]
184. Cardiovascular risk factors in type 2 diabetic patients: multifactorial intervention in primary care.
     Kidney Int Suppl. [Abstract] [Full-text]
185. Irbesartan is projected to be cost and life saving in a Spanish setting for treatment of patients with type 2 diabetes, hypertension, and microalbuminuria.
     Kidney Int Suppl. [Abstract] [Full-text]
186. ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis.
     Kidney Int Suppl. [Abstract] [Full-text]
187. Pharmacologic prevention or delay of type 2 diabetes mellitus.
     Ann Pharmacother, 39(1): 102-9. [Abstract] [Full-text]
188. Incretin mimetics as emerging treatments for type 2 diabetes.
     Ann Pharmacother, 39(1): 110-8. [Abstract] [Full-text]
189. Osteopenia: a bone disorder associated with diabetes mellitus.
     J Bone Miner Metab, 23(1): 58-68. [Abstract] [Full-text]
190. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes.
     Nature, 432(7020): 1027-32. [Abstract] [Full-text]
191. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.
     N Engl J Med, 351(26): 2683-93. [Abstract] [Full-text]
192. Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema.
     Br J Ophthalmol, 89(1): 74-80. [Abstract] [Full-text]
193. Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study.
     J Am Soc Nephrol, 16(1): 219-28. [Abstract] [Full-text]
194. Mouse models of diabetic nephropathy.
     J Am Soc Nephrol, 16(1): 27-45. [Abstract] [Full-text]
195. A low-protein diet concomitant with high calorie intake preserves renal function and structure in diabetic OLETF rats.
     Clin Exp Nephrol, 8(4): 322-30. [Abstract] [Full-text]
196. Pupil size before and after phacoemulsification in nondiabetic and diabetic patients.
     J Cataract Refract Surg, 30(12): 2543-50. [Abstract] [Full-text]
197. Longitudinal evaluation of memory performance and peripheral neuropathy in the Ins2C96Y Akita mice.
     Behav Brain Res, 157(1): 31-8. [Abstract] [Full-text]
198. Antidiabetic effects of extracts from Psidium guajava.
     J Ethnopharmacol, 96(3): 411-5. [Abstract] [Full-text]
199. Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial).
     Am J Cardiol, 95(1): 1-7. [Abstract] [Full-text]
200. Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness.
     J Neurosci Res, 79(1): 42-7. [Abstract] [Full-text]
201. TNF-alpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus.
     J Clin Immunol, 24(6): 591-9. [Abstract] [Full-text]
202. Factor structure of the Wide Range Assessment of Memory and Learning (WRAML) in children with insulin dependent diabetes mellitus (IDDM).
     Neuropsychol Dev Cogn C Child Neuropsychol, 10(4): 306-17. [Abstract] [Full-text]
203. Oxidative stress in diabetic pregnancy: SOD, CAT and GSH-Px activity and lipid peroxidation products.
     J Matern Fetal Neonatal Med, 16(6): 367-72. [Abstract] [Full-text]
204. Gestational diabetes: universal or selective screening?
     J Matern Fetal Neonatal Med, 16(6): 331-7. [Abstract] [Full-text]
205. Human fetal islet transplantation in type 1 diabetic patients: comparison of metabolic effects between single and multiple implantation regimens.
     Transplant Proc, 36(9): 2869-73. [Abstract] [Full-text]
206. Inflammation blockade improves pancreatic islet function.
     Transplant Proc, 36(9): 2864-5. [Abstract] [Full-text]
207. Long-term normalization of diabetes mellitus after xenotransplantation of fetal pancreatic islet cells into the blood stream without immunosuppresive therapy.
     Transplant Proc, 36(9): 2855-6. [Abstract] [Full-text]
208. Toxoplasmosis after a simultaneous pancreas and kidney transplantation.
     Transplant Proc, 36(9): 2843-4. [Abstract] [Full-text]
209. Prevalence of new-onset diabetes mellitus in Brazilian liver transplant recipients: association with HCV infection.
     Transplant Proc, 36(9): 2776-7. [Abstract] [Full-text]
210. Prevalence of type 2 diabetes mellitus in Brazilian liver transplant candidates: negative association with HCV status.
     Transplant Proc, 36(9): 2774-5. [Abstract] [Full-text]
211. Nutritional fats and the risk of type 2 diabetes and cancer.
     Physiol Behav, 83(4): 611-5. [Abstract] [Full-text]
212. beta-Adrenergic activation reveals impaired cardiac calcium handling at early stage of diabetes.
     Life Sci, 76(10): 1083-98. [Abstract] [Full-text]
213. Sympathetic modulation of the renal glucose transporter GLUT2 in diabetic rats.
     Auton Neurosci, 117(1): 54-61. [Abstract] [Full-text]
214. Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes.
     Hum Immunol, 66(1): 60-4. [Abstract] [Full-text]
215. Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody.
     Diabetes Res Clin Pract, 67(1): 63-9. [Abstract] [Full-text]
216. Predictive clinical parameters for therapeutic efficacy of rosiglitazone in Korean type 2 diabetes mellitus.
     Diabetes Res Clin Pract, 67(1): 43-52. [Abstract] [Full-text]
217. Accuracy and utility of a 10-test disk blood glucose meter.
     Diabetes Res Clin Pract, 67(1): 29-35. [Abstract] [Full-text]
218. Hypoglycemic effect of Du-zhong (Eucommia ulmoides Oliv.) leaves in streptozotocin-induced diabetic rats.
     Diabetes Res Clin Pract, 67(1): 22-8. [Abstract] [Full-text]
219. Advanced glycation endproducts--role in pathology of diabetic complications.
     Diabetes Res Clin Pract, 67(1): 3-21. [Abstract] [Full-text]
220. Expression of acute-phase response proteins in retinal Müller cells in diabetes.
     Invest Ophthalmol Vis Sci, 46(1): 349-57. [Abstract] [Full-text]
221. TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad.
     QJM, 98(1): 1-6. [Abstract] [Full-text]
222. Thiamine and vasculopathies.
     Prostaglandins Leukot Essent Fatty Acids, 72(2): 115-27. [Abstract] [Full-text]
223. Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review.
     Am J Prev Med, 28(1): 126-39. [Abstract] [Full-text]
224. Physical activity and diabetes risk in postmenopausal women.
     Am J Prev Med, 28(1): 19-25. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.